+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma



The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma



Gynecologic Oncology 148(2): 383-392



EpCAM is a transmembrane glycoprotein that functions as an epithelial marker in endometrial tissues. However, the correlation between EpCAM and endometrial carcinoma (EC) is not clear. This study investigated the association between EpCAM and EC. Immunohistochemistry staining and bioinformatics analysis disclosed the clinical importance of low EpCAM expression. The migratory ability of cells expressing low EpCAM levels was studied in transwell invasion assays in vitro and an orthotopic intra-uterine tumor injection model in vivo. The Connectivity MAP was used to identify drugs that effectively inhibit cells with low EpCAM expression. According to immunohistochemistry analysis results, low EpCAM expression was associated with an advanced stage and lymph node metastasis in patients with endometrioid EC, and high EpCAM expression favored survival. EpCAM silencing promoted cell invasion, and EpCAM re-expression in EpCAM-silenced EC cells attenuated their invasiveness. EpCAM suppression in an orthotopic uterine implantation model promoted the lymph node metastasis of EC cells. According to quantitative PCR and promoter reporter analyses, estrogen receptor alpha signaling regulated EpCAM expression by enhancing its promoter activity. As shown in the Connectivity MAP analysis, transamin inhibited the invasiveness of EpCAM-silenced EC cells. The loss of EpCAM may increase the malignancy of EC, and these findings provide new insights into the prognostic role of EpCAM in patients with EC.

(PDF emailed within 0-6 h: $19.90)

Accession: 065611203

Download citation: RISBibTeXText

PMID: 29208367

DOI: 10.1016/j.ygyno.2017.11.033


Related references

Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis. Tumour Biology 36(6): 4479-4485, 2015

The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker. Oncotarget 7(19): 27538-27551, 2018

EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression. Plos One 9(12): E114800, 2016

Mitochondrial changes in endometrial carcinoma: possible role in tumor diagnosis and prognosis (review). Oncology Reports 33(3): 1011-1018, 2015

Mitochondrial Dysfunctions in Type I Endometrial Carcinoma: Exploring Their Role in Oncogenesis and Tumor Progression. International Journal of Molecular Sciences 19(7), 2018

Upregulation of LncRNA BCYRN1 promotes tumor progression and enhances EpCAM expression in gastric carcinoma. Oncotarget 9(4): 4851-4861, 2018

Circulating stem cell-like EpCAM+tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. 2013

Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma. Applied Immunohistochemistry and Molecular Morphology 25(7): 481-488, 2016

Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus. Plos One 9(4): E93416, 2015

Prominin-1 and its role in tumor progression and assessment of clinical prognosis in systemic malignancies. Journal of Breast Cancer 16(2): 244, 2013

Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer. International Journal of Gynecological Cancer 23(2): 304-311, 2013

Clinicobiological progression and prognosis of oral squamous cell carcinoma in relation to the tumor invasive front: impact on prognosis. Acta Oto-Laryngologica 134(4): 416-424, 2014

The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. Journal of Thoracic Oncology 6(1): 209-217, 2011

Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Research 60(24): 7052-7056, 2001

High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma. Disease Markers 2014: 298795, 2015